State of β-adrenoreceptors in pulmonary hypertension due to COPD at high altitude

A. S. Sarybaev, I. S. Sabirov, A. S. Sydykov, A. A. Aldashev, T. Y. Murzapayazova, M. M. Mirrakhimov (Bishkek, Kyrgyzstan)

Source: Annual Congress 2002 - High altitude and hypoxia
Session: High altitude and hypoxia
Session type: Thematic Poster Session
Number: 694
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Abstract

Development of high altitude pulmonary hypertension (PH) is correlated with desensitization of β-adrenoreceptors (β-AR). We investigated the state of β-AR in lowlanders (LL) and high altitude natives (HL) with PH due to COPD. Pulmonary artery pressure (PAP) was evaluated invasively. β-AR density (Bmax) and dissociation constant (Kd) on the blood lymphocytes were measured at baseline while room air breathing and during hypoxic challenge (FiO2=0.1 for 30 min). Results are presented in the table. Bmax and Kd at baseline in HL with PH due to COPD were significantly higher than in LL. Acute hypoxia decreased Bmax and Kd in LL while increased them in LL. Thus in patients with COPD changes in β-AR density are observed. During acute hypoxia changes of β-AR density depends on the severity of the disease and altitude of residence testifying development of the desensitization of β-AR in severe PH.
Legend. # - p<0,05 compared to group 1; * -p<0,05 - compared to baseline value; Group 1 - HL with moderate COPD; group 2 - LL with moderate COPD; group 3 - LL with severe COPD.

Group 1 (n=9)Group 2 (n=9)Group 3 (n=9)
PAPmean (mm Hg)Baseline43,4±]3,219,7±]1,1#33,0±]1,2#
Hypoxia53,3±]2,1*26,4±]2,0*39,8±]1,5*
Bmax (fmol/106 cells)Baseline11,9±]2,414,88±]0,39#3,99±]0,25#
Hypoxia7,98±]0,73*5,56±]0,566,73±]0,98
KdBaseline2,3±]0,811,62±]0,350,61±]0,16#
Hypoxia1,01±]0,26*1,22±]0,240,82±]0,43




Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. S. Sarybaev, I. S. Sabirov, A. S. Sydykov, A. A. Aldashev, T. Y. Murzapayazova, M. M. Mirrakhimov (Bishkek, Kyrgyzstan). State of β-adrenoreceptors in pulmonary hypertension due to COPD at high altitude. Eur Respir J 2002; 20: Suppl. 38, 694

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension due to COPD at high altitude
Source: Eur Respir J 2002; 20: Suppl. 38, 99s
Year: 2002

High-altitude disease
Source: Respipedia Article
Year: 2017

COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006


Endothelin and high altitude pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Higher pulmonary artery pressure in children than in adults upon fast ascent to high altitude
Source: Eur Respir J 2008; 32: 664-669
Year: 2008



Prevalence of established and exercise induced pulmonary hypertension in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

Right and left ventricular function in lowlanders with COPD travelling to moderate altitude
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Calcium channel activity in lowlanders and in highlanders with pulmonary hypertension due to chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 99s
Year: 2002

Pulmonary hemodynamics in highlanders with high altitude pulmonary hypertension in 1 year after finishing of sildenafil treatment
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005


Common genetic basis for pulmonary arterial hypertension and high altitude pulmonary edema
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018

Cerebral oxygenation in highlanders with high altitude pulmonary hypertension
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013


Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


Effects of sildenafil on secondary pulmonary hypertension in highlanders with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007

Travel to high altitude with pre-existing lung disease
Source: Eur Respir J 2007; 29: 770-792
Year: 2007



Cognitive performance in patients with chronic obstructive pulmonary disease at moderate altitude
Source: Annual Congress 2010 - Advances in lung function II
Year: 2010

Estimation of right ventricular function in highlanders with high altitude pulmonary hypertension and high altitude cor pulmonale
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Right ventricular function in highlanders with high altitude pulmonary hypertension and high altitude cor pulmonale
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010

Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Rating predominance of pulmonary hypertension, lung hyperinflation and left ventricular dysfunction in patients with moderate and severe COPD in Belarus
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015